Loading...

GCTK GLUCOTRACK INC Capital Structure Changes 8-K Filing

GLCT

GCTK

GLUCOTRACK INC

(GCTK)

2025 8-K

Show Summary

Show Summary

New Product Launches

Amendment to Equity Incenti...

Other Special Situation

Financial Statements

Investor Meetings

Investor Meetings

Bionic Initiative

Delisting Notice

Strategic Agreement

Financial Results

Conference Announcement

Equity Securities Sale

Management Change

Shareholder Update

ISO Certification

Warrant Exchange Update

Warrant Exchange

TechBio Showcase

Nasdaq Compliance Notice

Clinical Study Launch

Capital Structure Changes

Public Offering

BioFuture Meeting

Conference Announcement

Stockholder Meeting

Debt Conversion

Board Appointments

Management Change

Market Research Update

Convertible Promissory Note...

Convertible Promissory Notes

Regulation FD Disclosure

Private Placement

Appointment of Independent ...

Regulation FD Disclosure

Delisting Notice

Reverse Stock Split

Regulation FD Disclosure

Reverse Stock Split

Annual Meeting of Stockholders

Completion of Acquisition o...

Investor Presentation

Resignation and Appointment...

Appointment of Director

Public Offering

Annual Meeting of Shareholders

Delisting Extension Granted

External Links:

Glucotrack, Inc. issued 10,030,145 Series B Warrants and received notices to exchange 6,950,240 of these for 134,785,015 shares of Common Stock, with remaining warrants exchangeable for about 19,909,386 shares.

AI Assistant

GLUCOTRACK INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.